Mankind Pharma Ltd. News and Updates

Keep track of all breaking news on Mankind Pharma Ltd. from all sources in a single place.

Load latest

Mankind Pharma Ltd.

21 Jan 2025

2465.30

-3.58%

Mankind Pharma Share Price Falls After Macquarie Downgrade

NDTV Profit

Mankind's own domestic formulations business has been weak due to slower growth in acute therapies, which accounts for up to 65% of its revenue, Macquarie said.

Mankind Pharma Ltd.'s price crossed below 100Day SMA today

Mankind Pharma Ltd.

08 Jan 2025

2465.30

-3.58%

Complete Circle Capital's wealth management arm raises $3 million funding from Mankind Pharma promoters

livemint

Complete Circle Capital's wealth management division, established by Gurmeet Chadha and Kshitiz Mahajan in 2015, will utilize the funds to speed up its growth and expansion strategies.

Mankind Pharma Ltd.'s price crossed below 100Day SMA today

Mankind Pharma Pledges 56% Stake In Subsidiary Bharat Serums

NDTV Profit | 07 Jan 2025

Mankind Pharma Ltd.

26 Dec 2024

2465.30

-3.58%

Mankind Pharma, Innovent Biologics Partner To Launch Sintilimab In India

NDTV Profit

The collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region.

Mankind Pharma Ltd.'s price crossed below 100Day SMA today

Mankind Pharma, Innovent Biologics partner to bring immunotherapy drug sintilimab to India

Business Line | 26 Dec 2024 2 more

Mankind Pharma Ltd.

24 Dec 2024

2465.30

-3.58%

Mankind Pharma dips 5% on profit booking after listing of QIP shares

Business Standard

Mankind Pharma's shares hit a record high of Rs 3,050 on Monday and rallied 13 per cent in past four trading days

Mankind Pharma Ltd. has an average target of 2831.00 from 3 brokers.

Mankind Pharma Ltd.

23 Dec 2024

2465.30

-3.58%

Mankind Pharma Share Price Live blog for 23 Dec 2024

livemint

Mankind Pharma Share Price Today Live Updates : Mankind Pharma stock price went down today, 23 Dec 2024, by -4.48 %. The stock closed at 67 per share. The stock is currently trading at 64 per share. Investors should monitor Mankind Pharma stock price closely in the coming days and weeks to see how it reacts to the news.

Mankind Pharma Ltd.'s price crossed below 100Day SMA today

Mankind Pharma Ltd.

20 Dec 2024

2465.30

-3.58%

Mankind Pharma Share Price Live blog for 20 Dec 2024

livemint

Mankind Pharma Share Price Today Live Updates : Mankind Pharma stock price went down today, 20 Dec 2024, by -4.48 %. The stock closed at 67 per share. The stock is currently trading at 64 per share. Investors should monitor Mankind Pharma stock price closely in the coming days and weeks to see how it reacts to the news.

Mankind Pharma Ltd. is trading above its 50 day SMA of 2379.4

Mankind Pharma Ltd.

17 Dec 2024

2465.30

-3.58%

Mankind Pharma rises on launching QIP at floor price of Rs 2,616.55

Business Standard

The company launched its qualified institutional placement (QIP) at a floor price of Rs 2,616.55 per share aiming to raise up to Rs 3,000 crore

Mankind Pharma Ltd. has an average target of 2831.00 from 3 brokers.

Mankind Pharma Approves Share Sale Worth Rs 3,000 Crore To Institutions To Pare Debt

NDTV Profit | 17 Dec 2024

Mankind Pharma Ltd.

03 Dec 2024

2465.30

-3.58%

AstraZeneca India MD Says Pact With Mankind Pharma Helped Boost Asthma Drug's Reach

NDTV Profit

The pact with Mankind Pharma, announced in March 2024, was an exclusive agreement for distribution of budesonide and formoterol fumarate dihydrate drug under the brand name of 'Symbicort'.

Mankind Pharma Ltd.'s price crossed below 100Day SMA today

Mankind Pharma Ltd.

15 Nov 2024

2465.30

-3.58%

Mankind Pharma pledges 39.68% stake in Bharat Serums for Rs 5k cr NCDs

Business Standard

The capital raised through this pledge is expected to support Mankind Pharma's strategic initiatives and growth plans

Number of FII/FPI investors increased from 624 to 640 in Mar 2025 qtr.

Mankind Pharma Ltd.

08 Nov 2024

2465.30

-3.58%

Mankind Pharma To Become Debt-Free In Three Years. MD Rajeev Juneja Explains How

NDTV Profit

Juneja said that the company will clear debts totaling Rs 10,000 crore in three years through measures such as a Rs 3,000-crore QIP and sale of non-core assets.

29.68% Gain from 52W Low

Mankind Pharma Ltd. News and Updates

Keep track of all breaking news on Mankind Pharma Ltd. from all sources in a single place.